LH1513 is a dioxalate salt derivative of L-lysine with superior inhibitory activity against calcium oxalate (CaOx) crystallization compared to citrate and pyruvate. It demonstrates preventive efficacy in hyperoxaluria research, effectively reducing urinary CaOx crystal formation in Agxt knockout mouse models, supporting its investigation as a potential therapeutic agent.
Molekulargewicht:
356.17
Formel:
C10H11N2Na3O8
Target-Kategorie:
Mitochondrial Metabolism
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
